At a glance
- Originator St. Charles Pharmaceuticals
- Class Antipyretics; Non-opioid analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Pain in USA
- 24 Apr 2007 Phase-I development is ongoing
- 26 Aug 2002 Phase-I clinical trials in Pain in USA (unspecified route)